We use some essential cookies to make this website work.
We鈥檇 like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Guidance on the handling of slurry and manure to help reduce the spread of antibiotic resistant bacteria.
Change your protocol, update your authorisation, report safety issues, submit safety updates and complete your end-of-trial study report.
As with all products, the MHRA will keep its safety under close review.
Guidelines and guidance for vets, farmers and animal keepers on the responsible use of antimicrobials.
How marketing authorisation holders should inform MHRA of a signal or an ADR to a medicine.
Science and Innovation Ireland organised a visit for Dame Sally Davies, Chief Medical Officer (CMO) for England focussing on genomics, clinical Trials and in particular anti-microbial resistance (AMR).
Information about when you need to submit substantial amendments to a clinical trial including changes to the trial sponsor or legal representative, Investigational medicinal product certification and importation.
皇冠体育app MMAR provides guidance to those organizations aiming to claim credit for certification activities or use of organization approvals through Recognition.
Don鈥檛 include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we鈥檇 like to know more about your visit today. .